Open Government Canada
Notice: Prescription Drug List (PDL): Naloxone
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).